These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29791895)

  • 81. Pre-dinner administration increases the efficacy of proton pump inhibitors on refractory GERD symptoms in connective tissue disease patients.
    Iwata A; Ikeda K; Hirose K; Takatori H; Takahashi K; Sanayama Y; Tanaka S; Suto A; Nakajima H
    Mod Rheumatol; 2013 Mar; 23(2):357-64. PubMed ID: 22614239
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Esomeprazole for the treatment of GERD in infants ages 1-11 months.
    Winter H; Gunasekaran T; Tolia V; Gottrand F; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):14-20. PubMed ID: 22241513
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
    Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
    J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
    Hongo M; Miwa H; Kusano M;
    J Gastroenterol Hepatol; 2012 May; 27(5):913-8. PubMed ID: 22142515
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effects of structured follow-up and of more effective acid inhibitory treatment in the management of GORD patients in a Swedish primary-care setting: a randomized, open-label study.
    Ekesbo R; Sjöstedt S; Sörngård H
    Clin Drug Investig; 2011; 31(3):181-9. PubMed ID: 21288053
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland?
    Petryszyn P; Staniak A; Grzegrzolka J
    J Comp Eff Res; 2016 Mar; 5(2):169-78. PubMed ID: 26946951
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease.
    Jeon HK; Kim GH; Lee MW; Joo DC; Lee BE
    J Clin Med; 2022 Apr; 11(7):. PubMed ID: 35407572
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Use of a positional therapy device significantly improves nocturnal gastroesophageal reflux symptoms.
    Allampati S; Lopez R; Thota PN; Ray M; Birgisson S; Gabbard SL
    Dis Esophagus; 2017 Feb; 30(3):1-7. PubMed ID: 27629558
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgery.
    Mastracci L; Fiocca R; Engström C; Attwood S; Ell C; Galmiche JP; Hatlebakk JG; Långström G; Eklund S; Lind T; Lundell L
    Aliment Pharmacol Ther; 2017 May; 45(10):1339-1349. PubMed ID: 28326569
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
    Orlando RC; Monyak JT; Silberg DG
    Curr Med Res Opin; 2009 Sep; 25(9):2091-102. PubMed ID: 19601705
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment.
    Giannini EG; Zentilin P; Dulbecco P; Vigneri S; Scarlata P; Savarino V
    Am J Gastroenterol; 2008 Feb; 103(2):267-75. PubMed ID: 18289194
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease].
    Maev IV; Viuchnova ES; Balashova NN; Shchekina MI
    Eksp Klin Gastroenterol; 2003; (3):26-31, 116. PubMed ID: 14556543
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France.
    Bruley des Varannes S; Löfman HG; Karlsson M; Wahlqvist P; Ruth M; Furstnau ML; Despiégel N; Stålhammar NO
    BMC Gastroenterol; 2013 Feb; 13():39. PubMed ID: 23448382
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Obesity does not affect treatment outcomes with proton pump inhibitors.
    Sharma P; Vakil N; Monyak JT; Silberg DG
    J Clin Gastroenterol; 2013 Sep; 47(8):672-7. PubMed ID: 23442835
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evaluation of the GERD Impact Scale, an international, validated patient questionnaire, in daily practice. Results of the ALEGRIA study.
    Louis E; Tack J; Vandenhoven G; Taeter C
    Acta Gastroenterol Belg; 2009; 72(1):3-8. PubMed ID: 19402364
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg.
    Katz PO; Le Moigne A; Pollack C
    Clin Ther; 2017 May; 39(5):960-970. PubMed ID: 28431766
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Treatment of gastroesophageal reflux disease: two new oral formulations dexlansoprazole MR and esomezol (esomeprazole strontium).
    Parekh PJ; Oldfield EC; Johnson DA
    Expert Opin Pharmacother; 2014 Jun; 15(9):1215-22. PubMed ID: 24749891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.